Last reviewed · How we verify
Standard of Care Antiviral medications
Standard of Care Antiviral medications is a Antiviral agent (class varies by specific drug) Small molecule drug developed by New York Medical College. It is currently in Phase 3 development for Viral infections (specific indication depends on the particular antiviral agent used as standard of care).
Standard of care antiviral medications inhibit viral replication by targeting essential viral enzymes or proteins required for the viral life cycle.
New York Medical College is conducting multiple clinical trials for standard of care antiviral medications across various viral infections, including influenza, HIV, COVID-19, and CMV. These trials aim to optimize dosing, enhance efficacy, and explore combination therapies. Notably, the company is investigating Tivoxavir Marboxil for influenza and Letermovir for CMV in lung transplant recipients.
At a glance
| Generic name | Standard of Care Antiviral medications |
|---|---|
| Sponsor | New York Medical College |
| Drug class | Antiviral agent (class varies by specific drug) |
| Modality | Small molecule |
| Therapeutic area | Infectious Disease / Virology |
| Phase | Phase 3 |
Mechanism of action
Standard antiviral drugs work through multiple mechanisms depending on the specific virus and drug class, including inhibition of viral polymerases, proteases, reverse transcriptases, or neuraminidases. These mechanisms prevent viral replication, reduce viral load, and allow the immune system to clear the infection. The specific mechanism varies by drug (e.g., nucleoside analogues, protease inhibitors, neuraminidase inhibitors).
Approved indications
- Viral infections (specific indication depends on the particular antiviral agent used as standard of care)
Common side effects
- Nausea
- Headache
- Diarrhea
- Fatigue
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Standard of Care Antiviral medications CI brief — competitive landscape report
- Standard of Care Antiviral medications updates RSS · CI watch RSS
- New York Medical College portfolio CI
Frequently asked questions about Standard of Care Antiviral medications
What is Standard of Care Antiviral medications?
How does Standard of Care Antiviral medications work?
What is Standard of Care Antiviral medications used for?
Who makes Standard of Care Antiviral medications?
What drug class is Standard of Care Antiviral medications in?
What development phase is Standard of Care Antiviral medications in?
What are the side effects of Standard of Care Antiviral medications?
Related
- Drug class: All Antiviral agent (class varies by specific drug) drugs
- Manufacturer: New York Medical College — full pipeline
- Therapeutic area: All drugs in Infectious Disease / Virology
- Indication: Drugs for Viral infections (specific indication depends on the particular antiviral agent used as standard of care)
- Compare: Standard of Care Antiviral medications vs similar drugs
- Pricing: Standard of Care Antiviral medications cost, discount & access